Literature DB >> 25380804

The hypothalamus in Alzheimer's disease: a Golgi and electron microscope study.

Stavros J Baloyannis1, Ioannis Mavroudis2, Demetrios Mitilineos2, Ioannis S Baloyannis2, Vassiliki G Costa3.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by irreversible decline of mental faculties, emotional and behavioral changes, loss of motor skills, and dysfunction of autonomic nervous system and disruption of circadian rhythms (CRs). We attempted to describe the morphological findings of the hypothalamus in early cases of AD, focusing our study mostly on the suprachiasmatic nucleus (SCN), the supraoptic nucleus (SON), and the paraventricular nucleus (PVN). Samples were processed for electron microscopy and silver impregnation techniques. The hypothalamic nuclei demonstrated a substantial decrease in the neuronal population, which was particularly prominent in the SCN. Marked abbreviation of dendritic arborization, in association with spinal pathology, was also seen. The SON and PVN demonstrated a substantial number of dystrophic axons and abnormal spines. Alzheimer's pathology, such as deposits of amyloid-β peptide and neurofibrillary degeneration, was minimal. Electron microscopy revealed mitochondrial alterations in the cell body and the dendritic branches. The morphological alterations of the hypothalamic nuclei in early cases of AD may be related to the gradual alteration of CRs and the instability of autonomic regulation.
© The Author(s) 2014.

Entities:  

Keywords:  Alzheimer’s disease; Golgi staining; electron microscopy; hypothalamus

Mesh:

Year:  2014        PMID: 25380804     DOI: 10.1177/1533317514556876

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  21 in total

1.  Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer's disease.

Authors:  Jing Tian; Lan Guo; Shaomei Sui; Christopher Driskill; Aarron Phensy; Qi Wang; Esha Gauba; Jeffrey M Zigman; Russell H Swerdlow; Sven Kroener; Heng Du
Journal:  Sci Transl Med       Date:  2019-08-14       Impact factor: 17.956

Review 2.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

Review 3.  Circadian Rhythm Sleep-Wake Disorders in Older Adults.

Authors:  Jee Hyun Kim; Alexandria R Elkhadem; Jeanne F Duffy
Journal:  Sleep Med Clin       Date:  2022-06

Review 4.  Defining circadian disruption in neurodegenerative disorders.

Authors:  Christopher S Colwell
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 19.456

5.  Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Marzia Nuccetelli; Francesca Izzi; Giuseppe Sancesario; Andrea Cimini; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Placidi Fabio
Journal:  J Neurol       Date:  2017-09-12       Impact factor: 4.849

Review 6.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

Authors:  Makoto Ishii; Costantino Iadecola
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

7.  Extension of Mendelian Randomization to Identify Earliest Manifestations of Alzheimer Disease: Association of Genetic Risk Score for Alzheimer Disease With Lower Body Mass Index by Age 50 Years.

Authors:  Willa D Brenowitz; Scott C Zimmerman; Teresa J Filshtein; Kristine Yaffe; Stefan Walter; Thomas J Hoffmann; Eric Jorgenson; Rachel A Whitmer; M Maria Glymour
Journal:  Am J Epidemiol       Date:  2021-10-01       Impact factor: 4.897

8.  Moderate Changes in the Circadian System of Alzheimer's Disease Patients Detected in Their Home Environment.

Authors:  Kamila Weissová; Aleš Bartoš; Martin Sládek; Marta Nováková; Alena Sumová
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

9.  Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT study.

Authors:  Agostino Chiaravalloti; Francesco Ursini; Alessandro Fiorentini; Gaetano Barbagallo; Alessandro Martorana; Giacomo Koch; Mario Tavolozza; Orazio Schillaci
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

Review 10.  Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease.

Authors:  Jonathan Cedernaes; Ricardo S Osorio; Andrew W Varga; Korey Kam; Helgi B Schiöth; Christian Benedict
Journal:  Sleep Med Rev       Date:  2016-02-11       Impact factor: 11.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.